NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth.
Barbara RomanoEster PaganoFabio Arturo IannottiFabiana PiscitelliVincenzo BrancaleoneGiuseppe LucarielloMaria Francesca NanìFerdinando FiorinoRosa SparacoGiovanna VanacoreFederica Di TellaDonatella CiciaRuggero LionettiAlexandros MakriyannisMichael MalamasMarcello De LucaGiovanni ApreaMaria D'ArmientoRaffaele CapassoBernardo SbarroTommaso VenneriVincenzo Di MarzoFrancesca BorrelliAngelo A IzzoPublished in: British journal of pharmacology (2021)
Our results provide unprecedented data on the functional importance of NAAA in CRC progression and its mechanism. We propose this enzyme as a valid drug target for the treatment of CRC growth and development.